Antibiotic susceptibility patterns of Staphylococcus aureus isolates from Australian children
Aim: Staphylococcus aureus is an important cause of serious illness in children. Antibiotic resistance is an international problem and affects initial antibiotic choice. We aimed to describe susceptibility patterns of S. aureus isolates from Australian children to inform optimal empiric treatment o...
Gespeichert in:
Veröffentlicht in: | Journal of paediatrics and child health 2010-07, Vol.46 (7-8), p.404-411 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 411 |
---|---|
container_issue | 7-8 |
container_start_page | 404 |
container_title | Journal of paediatrics and child health |
container_volume | 46 |
creator | Wolf, Joshua Daley, Andrew J Tilse, Martyn H Nimmo, Graeme R Bell, Sydney Howell, Alison J Keil, Anthony D Lawrence, Andrew Curtis, Nigel |
description | Aim: Staphylococcus aureus is an important cause of serious illness in children. Antibiotic resistance is an international problem and affects initial antibiotic choice. We aimed to describe susceptibility patterns of S. aureus isolates from Australian children to inform optimal empiric treatment of staphylococcal infections in this population.
Methods: We analysed susceptibility data for all S. aureus isolates from children at Australian tertiary paediatric hospitals in 2006. Susceptibility rates were compared between hospitals and states, and with published studies of S. aureus isolates from Australian adults.
Results: Overall, the proportion of methicillin‐resistant S. aureus (MRSA) in Australian children was low (9.8%), and in each state it was less than for the comparable adult population. There were significant differences in susceptibility patterns between different states. Most MRSA isolates were susceptible to clindamycin (73%) and all isolates were reported as susceptible to vancomycin. Susceptibility patterns for isolates from bacteraemic patients were similar to those for isolates from all patients.
Conclusions: These data support current Australian recommendations for the use of flucloxacillin or a first‐generation cephalosporin as initial treatment of non‐life‐threatening staphylococcal infections. However, broad spectrum antibiotic therapy including agents that are effective against MRSA should be considered for more serious infections. Appropriate specimens should be collected for susceptibility testing to enable directed treatment for MRSA and other resistant organisms. This study highlights the importance of using local, age‐specific data in planning antibiotic treatment guidelines, as results vary substantially from city to city and between adults and children. |
doi_str_mv | 10.1111/j.1440-1754.2010.01751.x |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_754559435</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>754559435</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4651-6050e4980e4a4c721bff5a919165635179a759db2de9e4eefd6b0db083af05783</originalsourceid><addsrcrecordid>eNqNkc1u1DAUhS0EoqXwCshiwyrDdfyTZMFiNIIpVVUqFVQJCVmO46gePHFqO2Lm7XGYdhZsqBe-x_Z3rnR9EMIEFiSvD5sFYQwKUnG2KCHfQpZksXuGTo8Pz7MGygpWEzhBr2LcAEDJef0SnZTAmSBATtHP5ZBsa32yGscpajPOR2fTHo8qJROGiH2Pb5Ia7_bOa6_1FLGagsnFRu9UMhH3wW_xcoopKGfVgPWddV0ww2v0olcumjcP9Qx9__zp2-q8uPy6_rJaXhaaCU4KARwMa-q8KaarkrR9z1VDGiK4oJxUjap407VlZxrDjOk70ULXQk1VD7yq6Rl6f-g7Bn8_mZjk1uZZnFOD8VOU-Ts4bxjl_ycpAxC1gEy--4fc-CkMeYwMUYCmhCpD9QHSwccYTC_HYLcq7CUBOUclN3JORM6JyDkq-TcqucvWtw_9p3ZruqPxMZsMfDwAv60z-yc3lhfXq1llf3Hw25jM7uhX4ZcUFa24vL1ay_UPEOT69lxe0D8qi7Fe</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>733009207</pqid></control><display><type>article</type><title>Antibiotic susceptibility patterns of Staphylococcus aureus isolates from Australian children</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><creator>Wolf, Joshua ; Daley, Andrew J ; Tilse, Martyn H ; Nimmo, Graeme R ; Bell, Sydney ; Howell, Alison J ; Keil, Anthony D ; Lawrence, Andrew ; Curtis, Nigel</creator><creatorcontrib>Wolf, Joshua ; Daley, Andrew J ; Tilse, Martyn H ; Nimmo, Graeme R ; Bell, Sydney ; Howell, Alison J ; Keil, Anthony D ; Lawrence, Andrew ; Curtis, Nigel</creatorcontrib><description>Aim: Staphylococcus aureus is an important cause of serious illness in children. Antibiotic resistance is an international problem and affects initial antibiotic choice. We aimed to describe susceptibility patterns of S. aureus isolates from Australian children to inform optimal empiric treatment of staphylococcal infections in this population.
Methods: We analysed susceptibility data for all S. aureus isolates from children at Australian tertiary paediatric hospitals in 2006. Susceptibility rates were compared between hospitals and states, and with published studies of S. aureus isolates from Australian adults.
Results: Overall, the proportion of methicillin‐resistant S. aureus (MRSA) in Australian children was low (9.8%), and in each state it was less than for the comparable adult population. There were significant differences in susceptibility patterns between different states. Most MRSA isolates were susceptible to clindamycin (73%) and all isolates were reported as susceptible to vancomycin. Susceptibility patterns for isolates from bacteraemic patients were similar to those for isolates from all patients.
Conclusions: These data support current Australian recommendations for the use of flucloxacillin or a first‐generation cephalosporin as initial treatment of non‐life‐threatening staphylococcal infections. However, broad spectrum antibiotic therapy including agents that are effective against MRSA should be considered for more serious infections. Appropriate specimens should be collected for susceptibility testing to enable directed treatment for MRSA and other resistant organisms. This study highlights the importance of using local, age‐specific data in planning antibiotic treatment guidelines, as results vary substantially from city to city and between adults and children.</description><identifier>ISSN: 1034-4810</identifier><identifier>EISSN: 1440-1754</identifier><identifier>DOI: 10.1111/j.1440-1754.2010.01751.x</identifier><identifier>PMID: 20546101</identifier><language>eng</language><publisher>Melbourne, Australia: Blackwell Publishing Asia</publisher><subject>Anti-Bacterial Agents - administration & dosage ; Anti-Bacterial Agents - pharmacology ; Antibiotic resistance ; Antibiotics ; Australia ; bacteremia ; bacterial ; Child ; Child, Preschool ; Children ; Clindamycin - pharmacology ; Clindamycin - therapeutic use ; Drug resistance ; Drug Resistance, Microbial - drug effects ; Hospitals, Pediatric ; Humans ; Infection ; Methicillin-Resistant Staphylococcus aureus ; Pediatrics ; Staphylococcal Infections - drug therapy ; Staphylococcus aureus ; Staphylococcus aureus - drug effects ; Staphylococcus infections</subject><ispartof>Journal of paediatrics and child health, 2010-07, Vol.46 (7-8), p.404-411</ispartof><rights>2010 The Authors. Journal compilation © 2010 Paediatrics and Child Health Division (Royal Australasian College of Physicians)</rights><rights>Journal compilation © 2010 Paediatrics and Child Health Division (Royal Australasian College of Physicians)</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4651-6050e4980e4a4c721bff5a919165635179a759db2de9e4eefd6b0db083af05783</citedby><cites>FETCH-LOGICAL-c4651-6050e4980e4a4c721bff5a919165635179a759db2de9e4eefd6b0db083af05783</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1440-1754.2010.01751.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1440-1754.2010.01751.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>315,781,785,1418,27929,27930,45579,45580</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20546101$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wolf, Joshua</creatorcontrib><creatorcontrib>Daley, Andrew J</creatorcontrib><creatorcontrib>Tilse, Martyn H</creatorcontrib><creatorcontrib>Nimmo, Graeme R</creatorcontrib><creatorcontrib>Bell, Sydney</creatorcontrib><creatorcontrib>Howell, Alison J</creatorcontrib><creatorcontrib>Keil, Anthony D</creatorcontrib><creatorcontrib>Lawrence, Andrew</creatorcontrib><creatorcontrib>Curtis, Nigel</creatorcontrib><title>Antibiotic susceptibility patterns of Staphylococcus aureus isolates from Australian children</title><title>Journal of paediatrics and child health</title><addtitle>J Paediatr Child Health</addtitle><description>Aim: Staphylococcus aureus is an important cause of serious illness in children. Antibiotic resistance is an international problem and affects initial antibiotic choice. We aimed to describe susceptibility patterns of S. aureus isolates from Australian children to inform optimal empiric treatment of staphylococcal infections in this population.
Methods: We analysed susceptibility data for all S. aureus isolates from children at Australian tertiary paediatric hospitals in 2006. Susceptibility rates were compared between hospitals and states, and with published studies of S. aureus isolates from Australian adults.
Results: Overall, the proportion of methicillin‐resistant S. aureus (MRSA) in Australian children was low (9.8%), and in each state it was less than for the comparable adult population. There were significant differences in susceptibility patterns between different states. Most MRSA isolates were susceptible to clindamycin (73%) and all isolates were reported as susceptible to vancomycin. Susceptibility patterns for isolates from bacteraemic patients were similar to those for isolates from all patients.
Conclusions: These data support current Australian recommendations for the use of flucloxacillin or a first‐generation cephalosporin as initial treatment of non‐life‐threatening staphylococcal infections. However, broad spectrum antibiotic therapy including agents that are effective against MRSA should be considered for more serious infections. Appropriate specimens should be collected for susceptibility testing to enable directed treatment for MRSA and other resistant organisms. This study highlights the importance of using local, age‐specific data in planning antibiotic treatment guidelines, as results vary substantially from city to city and between adults and children.</description><subject>Anti-Bacterial Agents - administration & dosage</subject><subject>Anti-Bacterial Agents - pharmacology</subject><subject>Antibiotic resistance</subject><subject>Antibiotics</subject><subject>Australia</subject><subject>bacteremia</subject><subject>bacterial</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Children</subject><subject>Clindamycin - pharmacology</subject><subject>Clindamycin - therapeutic use</subject><subject>Drug resistance</subject><subject>Drug Resistance, Microbial - drug effects</subject><subject>Hospitals, Pediatric</subject><subject>Humans</subject><subject>Infection</subject><subject>Methicillin-Resistant Staphylococcus aureus</subject><subject>Pediatrics</subject><subject>Staphylococcal Infections - drug therapy</subject><subject>Staphylococcus aureus</subject><subject>Staphylococcus aureus - drug effects</subject><subject>Staphylococcus infections</subject><issn>1034-4810</issn><issn>1440-1754</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkc1u1DAUhS0EoqXwCshiwyrDdfyTZMFiNIIpVVUqFVQJCVmO46gePHFqO2Lm7XGYdhZsqBe-x_Z3rnR9EMIEFiSvD5sFYQwKUnG2KCHfQpZksXuGTo8Pz7MGygpWEzhBr2LcAEDJef0SnZTAmSBATtHP5ZBsa32yGscpajPOR2fTHo8qJROGiH2Pb5Ia7_bOa6_1FLGagsnFRu9UMhH3wW_xcoopKGfVgPWddV0ww2v0olcumjcP9Qx9__zp2-q8uPy6_rJaXhaaCU4KARwMa-q8KaarkrR9z1VDGiK4oJxUjap407VlZxrDjOk70ULXQk1VD7yq6Rl6f-g7Bn8_mZjk1uZZnFOD8VOU-Ts4bxjl_ycpAxC1gEy--4fc-CkMeYwMUYCmhCpD9QHSwccYTC_HYLcq7CUBOUclN3JORM6JyDkq-TcqucvWtw_9p3ZruqPxMZsMfDwAv60z-yc3lhfXq1llf3Hw25jM7uhX4ZcUFa24vL1ay_UPEOT69lxe0D8qi7Fe</recordid><startdate>201007</startdate><enddate>201007</enddate><creator>Wolf, Joshua</creator><creator>Daley, Andrew J</creator><creator>Tilse, Martyn H</creator><creator>Nimmo, Graeme R</creator><creator>Bell, Sydney</creator><creator>Howell, Alison J</creator><creator>Keil, Anthony D</creator><creator>Lawrence, Andrew</creator><creator>Curtis, Nigel</creator><general>Blackwell Publishing Asia</general><general>Blackwell Publishing Ltd</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>ASE</scope><scope>FPQ</scope><scope>K6X</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope><scope>7QL</scope><scope>C1K</scope><scope>M7N</scope></search><sort><creationdate>201007</creationdate><title>Antibiotic susceptibility patterns of Staphylococcus aureus isolates from Australian children</title><author>Wolf, Joshua ; Daley, Andrew J ; Tilse, Martyn H ; Nimmo, Graeme R ; Bell, Sydney ; Howell, Alison J ; Keil, Anthony D ; Lawrence, Andrew ; Curtis, Nigel</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4651-6050e4980e4a4c721bff5a919165635179a759db2de9e4eefd6b0db083af05783</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Anti-Bacterial Agents - administration & dosage</topic><topic>Anti-Bacterial Agents - pharmacology</topic><topic>Antibiotic resistance</topic><topic>Antibiotics</topic><topic>Australia</topic><topic>bacteremia</topic><topic>bacterial</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Children</topic><topic>Clindamycin - pharmacology</topic><topic>Clindamycin - therapeutic use</topic><topic>Drug resistance</topic><topic>Drug Resistance, Microbial - drug effects</topic><topic>Hospitals, Pediatric</topic><topic>Humans</topic><topic>Infection</topic><topic>Methicillin-Resistant Staphylococcus aureus</topic><topic>Pediatrics</topic><topic>Staphylococcal Infections - drug therapy</topic><topic>Staphylococcus aureus</topic><topic>Staphylococcus aureus - drug effects</topic><topic>Staphylococcus infections</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wolf, Joshua</creatorcontrib><creatorcontrib>Daley, Andrew J</creatorcontrib><creatorcontrib>Tilse, Martyn H</creatorcontrib><creatorcontrib>Nimmo, Graeme R</creatorcontrib><creatorcontrib>Bell, Sydney</creatorcontrib><creatorcontrib>Howell, Alison J</creatorcontrib><creatorcontrib>Keil, Anthony D</creatorcontrib><creatorcontrib>Lawrence, Andrew</creatorcontrib><creatorcontrib>Curtis, Nigel</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>British Nursing Index</collection><collection>British Nursing Index (BNI) (1985 to Present)</collection><collection>British Nursing Index</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><collection>MEDLINE - Academic</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><jtitle>Journal of paediatrics and child health</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wolf, Joshua</au><au>Daley, Andrew J</au><au>Tilse, Martyn H</au><au>Nimmo, Graeme R</au><au>Bell, Sydney</au><au>Howell, Alison J</au><au>Keil, Anthony D</au><au>Lawrence, Andrew</au><au>Curtis, Nigel</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Antibiotic susceptibility patterns of Staphylococcus aureus isolates from Australian children</atitle><jtitle>Journal of paediatrics and child health</jtitle><addtitle>J Paediatr Child Health</addtitle><date>2010-07</date><risdate>2010</risdate><volume>46</volume><issue>7-8</issue><spage>404</spage><epage>411</epage><pages>404-411</pages><issn>1034-4810</issn><eissn>1440-1754</eissn><abstract>Aim: Staphylococcus aureus is an important cause of serious illness in children. Antibiotic resistance is an international problem and affects initial antibiotic choice. We aimed to describe susceptibility patterns of S. aureus isolates from Australian children to inform optimal empiric treatment of staphylococcal infections in this population.
Methods: We analysed susceptibility data for all S. aureus isolates from children at Australian tertiary paediatric hospitals in 2006. Susceptibility rates were compared between hospitals and states, and with published studies of S. aureus isolates from Australian adults.
Results: Overall, the proportion of methicillin‐resistant S. aureus (MRSA) in Australian children was low (9.8%), and in each state it was less than for the comparable adult population. There were significant differences in susceptibility patterns between different states. Most MRSA isolates were susceptible to clindamycin (73%) and all isolates were reported as susceptible to vancomycin. Susceptibility patterns for isolates from bacteraemic patients were similar to those for isolates from all patients.
Conclusions: These data support current Australian recommendations for the use of flucloxacillin or a first‐generation cephalosporin as initial treatment of non‐life‐threatening staphylococcal infections. However, broad spectrum antibiotic therapy including agents that are effective against MRSA should be considered for more serious infections. Appropriate specimens should be collected for susceptibility testing to enable directed treatment for MRSA and other resistant organisms. This study highlights the importance of using local, age‐specific data in planning antibiotic treatment guidelines, as results vary substantially from city to city and between adults and children.</abstract><cop>Melbourne, Australia</cop><pub>Blackwell Publishing Asia</pub><pmid>20546101</pmid><doi>10.1111/j.1440-1754.2010.01751.x</doi><tpages>8</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1034-4810 |
ispartof | Journal of paediatrics and child health, 2010-07, Vol.46 (7-8), p.404-411 |
issn | 1034-4810 1440-1754 |
language | eng |
recordid | cdi_proquest_miscellaneous_754559435 |
source | MEDLINE; Access via Wiley Online Library |
subjects | Anti-Bacterial Agents - administration & dosage Anti-Bacterial Agents - pharmacology Antibiotic resistance Antibiotics Australia bacteremia bacterial Child Child, Preschool Children Clindamycin - pharmacology Clindamycin - therapeutic use Drug resistance Drug Resistance, Microbial - drug effects Hospitals, Pediatric Humans Infection Methicillin-Resistant Staphylococcus aureus Pediatrics Staphylococcal Infections - drug therapy Staphylococcus aureus Staphylococcus aureus - drug effects Staphylococcus infections |
title | Antibiotic susceptibility patterns of Staphylococcus aureus isolates from Australian children |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-14T01%3A29%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Antibiotic%20susceptibility%20patterns%20of%20Staphylococcus%20aureus%20isolates%20from%20Australian%20children&rft.jtitle=Journal%20of%20paediatrics%20and%20child%20health&rft.au=Wolf,%20Joshua&rft.date=2010-07&rft.volume=46&rft.issue=7-8&rft.spage=404&rft.epage=411&rft.pages=404-411&rft.issn=1034-4810&rft.eissn=1440-1754&rft_id=info:doi/10.1111/j.1440-1754.2010.01751.x&rft_dat=%3Cproquest_cross%3E754559435%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=733009207&rft_id=info:pmid/20546101&rfr_iscdi=true |